Jacques De Grève

2PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 15, 2022
The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer.

Carolien Eggermont, Philippe Giron, Maxim Noeparast

|Nov 19, 2020
Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancer.

Philippe Giron, Carolien Eggermont, Amir Noeparast

Pageof 1

Frequent Collaborators